Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 14/20 | 0.45 |
| ▸ | TAS1R1 | Q7RTX1 | 13/20 | 0.45 |
| ▸ | TAS1R2 | Q8TE23 | 13/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7652879 | 0.95 | TAS1R3 (0.42) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL2777861 | 0.87 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL10587923 | 0.87 | TAS1R3 (0.35) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL9019898 | 0.86 | TAS1R3 (0.40) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL996758 | 0.86 | CES2 (0.43) | CES2CES1ALDH1A1HTTALOX15 | |
| SCHEMBL1657 | 0.83 | CES2 (0.48) | CES2CES1ALDH1A1HTTKDM4C | |
| SCHEMBL18774737 | 0.81 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL6538271 | 0.80 | CES2 (0.46) | CES2CES1ALDH1A1HTTALOX15 | |
| SCHEMBL10631305 | 0.80 | CES2 (0.38) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL2295776 | 0.80 | ALDH1A1 (0.39) | CES2CES1ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357145-A1 | C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-11-09 | — | — | US | disclosed |
| CN-108698982-B | Fluorine atom-containing compound and use thereof | 日产化学工业株式会社 | 2021-07-16 | — | — | CN | disclosed |
| EP-3404017-B1 | FLUORINE ATOM-CONTAINING COMPOUND AND USE THEREOF | NISSAN CHEMICAL IND LTD (JP) | 2020-05-13 | — | — | EP | disclosed |
| US-10590287-B2 | Charge-transporting varnish and organic electroluminescent element | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| EP-3252840-B1 | VARNISH FOR FORMATION OF CHARGE-TRANSPORTING THIN FILM | NISSAN CHEMICAL CORP (JP) | 2020-03-11 | — | — | EP | disclosed |
| EP-3309851-B1 | CHARGE-TRANSPORTING VARNISH AND ORGANIC ELECTROLUMINESCENT ELEMENT | NISSAN CHEMICAL CORP (JP) | 2020-01-01 | — | — | EP | disclosed |
| CN-107710440-B | Charge-transporting varnish and organic electroluminescent element | 日产化学工业株式会社 | 2019-12-24 | — | — | CN | disclosed |
| US-10336686-B2 | Fluorine atom-containing compound and use thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-07-02 | — | — | US | disclosed |
| US-10301484-B2 | Varnish for formation of charge-transporting thin film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-05-28 | — | — | US | disclosed |
| US-20190031600-A1 | FLUORINE ATOM-CONTAINING COMPOUND AND USE THEREOF | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-01-31 | — | — | US | disclosed |
| CN-102993017-B | optically active additive, liquid crystal formula and forming method thereof, and liquid crystal display | IND TECH RES INST | 2015-04-29 | — | — | CN | disclosed |
| US-8754107-B2 | Aminopyrrolidines as chemokine receptor antagonists | ABBVIE INC. (US) | 2014-06-17 | — | — | US | disclosed |
| US-8449953-B2 | Chiral dopants, liquid crystal matrix and manufacturing method thereof and liquid crystal display | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-05-28 | — | — | US | disclosed |
| CN-102993017-A | Optically active additive, liquid crystal formula and forming method thereof, and liquid crystal display | IND TECH RES INST | 2013-03-27 | — | — | CN | disclosed |
| US-20130063693-A1 | CHIRAL DOPANTS, LIQUID CRYSTAL MATRIX AND MANUFACTURING METHOD THEREOF AND LIQUID CRYSTAL DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-03-14 | — | — | US | disclosed |
| US-6828467-B2 | Industrial process of the hydrogenolysis of one hydroxyl or methanol group of a fluorinated benzenedimethanol carried out in a solvent in the presence of a catalyst; 2,3,5,6-tetra-fluorobenzyl alcohol from the 4-methyl derivative | SHOWA DENKO K.K. (JP) | 2004-12-07 | — | — | US | disclosed |
| EP-1322584-B1 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | SHOWA DENKO K.K. (JP) | 2004-01-15 | — | — | US | disclosed |
| EP-1322584-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | Showa Denko K.K. (JP) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002026678-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336686-B2 | Fluorine atom-containing compound and use thereof | ARF1, ARF5, ARFGAP1 | TAS1R3 3689/4885TAS1R1 2966/4885TAS1R2 3744/4885 |
| US-20230357145-A1 | C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | HTR4, HTR2C, CNR2 | TAS1R3 2205/4885TAS1R1 2659/4885TAS1R2 2507/4885 |
| US-10590287-B2 | Charge-transporting varnish and organic electroluminescent element | SLCO4C1, SLCO2A1, SLC26A3 | TAS1R3 630/4885TAS1R1 562/4885TAS1R2 652/4885 |
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | ADH1C, ADH5, ADH1A | TAS1R3 3075/4885TAS1R1 3662/4885TAS1R2 3716/4885 |
| US-20130063693-A1 | CHIRAL DOPANTS, LIQUID CRYSTAL MATRIX AND MANUFACTURING METHOD THEREOF AND LIQUID CRYSTAL DISPLAY | CNPY2, YBX3, CCR3 | TAS1R3 1214/4885TAS1R1 2344/4885TAS1R2 2094/4885 |
| US-20190031600-A1 | FLUORINE ATOM-CONTAINING COMPOUND AND USE THEREOF | ARF1, ARF5, ARFGAP1 | TAS1R3 3689/4885TAS1R1 2966/4885TAS1R2 3744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.